CY1123061T1 - Μεθοδοι διαχωρισμου διαστερεοϊσομερων φωσφορικης γεμσιταβινης - Google Patents
Μεθοδοι διαχωρισμου διαστερεοϊσομερων φωσφορικης γεμσιταβινηςInfo
- Publication number
- CY1123061T1 CY1123061T1 CY20201100477T CY201100477T CY1123061T1 CY 1123061 T1 CY1123061 T1 CY 1123061T1 CY 20201100477 T CY20201100477 T CY 20201100477T CY 201100477 T CY201100477 T CY 201100477T CY 1123061 T1 CY1123061 T1 CY 1123061T1
- Authority
- CY
- Cyprus
- Prior art keywords
- phosphate
- gemcitabine
- diastereisomers
- separation
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Αυτή η αίτηση σχετίζεται με μια μέθοδο διαχωρισμού των φωσφορικών διαστερεοϊσομερών της [φαινυλο-βενζοξυ-L-αλανινυλο)]-φωσφορικής γεμσιταβίνης (NUC-I031) χρησιμοποιώντας κρυστάλλωση. Πιο συγκεκριμένα, η κρυστάλλωση από ισοπροπυλική αλκοόλη παρέχει [φαινυλο-βενζοξυ-L-αλανινυλο)]- (S)-φωσφορική γεμσιταβίνη σε υψηλή διαστερεοϊσομερικώς καθαρή μορφή. Αυτή η αίτηση σχετίζεται επίσης με μια κρυσταλλική μορφή της [φαινυλο-βενζοξυ-L-αλανινυλο)]- (S)-φωσφορικής γεμσιταβίνης.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1417644.0A GB201417644D0 (en) | 2014-10-06 | 2014-10-06 | Method of separating phosphate diastereoisomers |
PCT/GB2015/052839 WO2016055769A1 (en) | 2014-10-06 | 2015-09-29 | Methods of separating gemcitabine-phosphate diastereoisomers |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1123061T1 true CY1123061T1 (el) | 2021-10-29 |
Family
ID=51946917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20201100477T CY1123061T1 (el) | 2014-10-06 | 2020-05-25 | Μεθοδοι διαχωρισμου διαστερεοϊσομερων φωσφορικης γεμσιταβινης |
Country Status (29)
Country | Link |
---|---|
US (1) | US10669300B2 (el) |
EP (2) | EP3204398B1 (el) |
JP (2) | JP6893172B2 (el) |
KR (1) | KR102532498B1 (el) |
CN (2) | CN107108682B (el) |
AU (2) | AU2015329767B2 (el) |
CA (1) | CA2959977C (el) |
CL (1) | CL2017000819A1 (el) |
CY (1) | CY1123061T1 (el) |
DK (1) | DK3204398T3 (el) |
EA (1) | EA033118B1 (el) |
ES (1) | ES2793957T3 (el) |
GB (1) | GB201417644D0 (el) |
HR (1) | HRP20200849T1 (el) |
HU (1) | HUE050882T2 (el) |
IL (1) | IL251125B (el) |
LT (1) | LT3204398T (el) |
MA (1) | MA41039B1 (el) |
ME (1) | ME03730B (el) |
MX (2) | MX2020003758A (el) |
MY (1) | MY183302A (el) |
PH (1) | PH12017500586A1 (el) |
PL (1) | PL3204398T3 (el) |
PT (1) | PT3204398T (el) |
RS (1) | RS60634B1 (el) |
SG (2) | SG10201902952SA (el) |
SI (1) | SI3204398T1 (el) |
WO (1) | WO2016055769A1 (el) |
ZA (1) | ZA201701723B (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0317009D0 (en) * | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
CN104903339A (zh) | 2012-11-16 | 2015-09-09 | 卡迪夫大学学院顾问有限公司 | 用于制备核苷前体药物的方法 |
LT3160978T (lt) | 2014-06-25 | 2020-08-25 | NuCana plc | Gemcitabino provaistai |
NO3119794T3 (el) | 2014-06-25 | 2018-03-10 | ||
GB201417644D0 (en) | 2014-10-06 | 2014-11-19 | Nucana Biomed Ltd | Method of separating phosphate diastereoisomers |
CN106543220A (zh) * | 2015-09-16 | 2017-03-29 | 博瑞生物医药(苏州)股份有限公司 | 氨基磷酸酯化合物及其制备方法和晶体 |
CN106539810B (zh) * | 2015-09-16 | 2021-03-09 | 济南高合医疗科技有限公司 | 一种富集了nuc-1031单一异构体的组合物及其制备方法和用途 |
CN106543252A (zh) * | 2015-09-16 | 2017-03-29 | 博瑞生物医药(苏州)股份有限公司 | 核苷氨基磷酸酯类前药的制备方法及其中间体 |
KR20180063075A (ko) | 2015-10-05 | 2018-06-11 | 뉴카나 피엘씨 | 조합 요법 |
SG11201804774YA (en) | 2015-12-11 | 2018-07-30 | NuCana plc | Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031 |
GB201522771D0 (en) * | 2015-12-23 | 2016-02-03 | Nucana Biomed Ltd | Crystalline form of a phosphate derivative |
CN107652342A (zh) * | 2016-07-23 | 2018-02-02 | 江苏万高药业股份有限公司 | 核苷氨基磷酸酯类前药的多晶型及其制备方法 |
GB201709471D0 (en) | 2017-06-14 | 2017-07-26 | Nucana Biomed Ltd | Diastereoselective synthesis of hosphate derivatives |
CN107400156B (zh) * | 2017-09-19 | 2020-01-31 | 北京大学 | 一种分离麦角甾烷型三萜25r-与25s-差向异构体的方法 |
CN115028594A (zh) * | 2020-06-03 | 2022-09-09 | 吴卫东 | 恩替他滨药用前体化合物及其制备方法和医学用途 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1254092T3 (da) * | 2000-02-11 | 2004-03-15 | Degussa | Resolvering af DL-racemiske blandinger |
GB0317009D0 (en) * | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
FR2954310B1 (fr) * | 2009-12-18 | 2014-07-25 | Univ Rouen | Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle |
CN104903339A (zh) | 2012-11-16 | 2015-09-09 | 卡迪夫大学学院顾问有限公司 | 用于制备核苷前体药物的方法 |
WO2014204856A1 (en) | 2013-06-17 | 2014-12-24 | Catabasis Pharmaceuticals, Inc. | Fatty acid anticancer derivatives and their uses |
CA2931458A1 (en) * | 2013-11-27 | 2015-06-04 | Idenix Pharmaceuticals Llc | Nucleotides for the treatment of liver cancer |
LT3160978T (lt) | 2014-06-25 | 2020-08-25 | NuCana plc | Gemcitabino provaistai |
NO3119794T3 (el) * | 2014-06-25 | 2018-03-10 | ||
WO2016012781A1 (en) | 2014-07-22 | 2016-01-28 | Nucana Biomed Limited | Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate |
GB201417644D0 (en) | 2014-10-06 | 2014-11-19 | Nucana Biomed Ltd | Method of separating phosphate diastereoisomers |
PT3197456T (pt) | 2015-05-14 | 2018-05-22 | NuCana plc | Tratamentos de cancro |
KR20180063075A (ko) | 2015-10-05 | 2018-06-11 | 뉴카나 피엘씨 | 조합 요법 |
SG11201804774YA (en) | 2015-12-11 | 2018-07-30 | NuCana plc | Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031 |
CA3008769A1 (en) | 2015-12-23 | 2017-06-29 | NuCana plc | Combination therapy comprising nuc-1031 and cisplatin |
GB201522771D0 (en) | 2015-12-23 | 2016-02-03 | Nucana Biomed Ltd | Crystalline form of a phosphate derivative |
PT3393478T (pt) | 2015-12-23 | 2020-03-24 | NuCana plc | Terapia combinada |
-
2014
- 2014-10-06 GB GBGB1417644.0A patent/GB201417644D0/en not_active Ceased
-
2015
- 2015-09-29 US US15/514,673 patent/US10669300B2/en active Active
- 2015-09-29 SG SG10201902952SA patent/SG10201902952SA/en unknown
- 2015-09-29 KR KR1020177012012A patent/KR102532498B1/ko active IP Right Grant
- 2015-09-29 DK DK15782005.1T patent/DK3204398T3/da active
- 2015-09-29 WO PCT/GB2015/052839 patent/WO2016055769A1/en active Application Filing
- 2015-09-29 CN CN201580054225.8A patent/CN107108682B/zh active Active
- 2015-09-29 PL PL15782005T patent/PL3204398T3/pl unknown
- 2015-09-29 SI SI201531226T patent/SI3204398T1/sl unknown
- 2015-09-29 PT PT157820051T patent/PT3204398T/pt unknown
- 2015-09-29 LT LTEP15782005.1T patent/LT3204398T/lt unknown
- 2015-09-29 JP JP2017518474A patent/JP6893172B2/ja active Active
- 2015-09-29 EA EA201790794A patent/EA033118B1/ru unknown
- 2015-09-29 MX MX2020003758A patent/MX2020003758A/es unknown
- 2015-09-29 MY MYPI2017000434A patent/MY183302A/en unknown
- 2015-09-29 MA MA41039A patent/MA41039B1/fr unknown
- 2015-09-29 CA CA2959977A patent/CA2959977C/en active Active
- 2015-09-29 ME MEP-2020-104A patent/ME03730B/me unknown
- 2015-09-29 HU HUE15782005A patent/HUE050882T2/hu unknown
- 2015-09-29 CN CN202011494200.9A patent/CN112552362A/zh active Pending
- 2015-09-29 SG SG11201701885UA patent/SG11201701885UA/en unknown
- 2015-09-29 MX MX2017004446A patent/MX2017004446A/es active IP Right Grant
- 2015-09-29 RS RS20200611A patent/RS60634B1/sr unknown
- 2015-09-29 ES ES15782005T patent/ES2793957T3/es active Active
- 2015-09-29 EP EP15782005.1A patent/EP3204398B1/en active Active
- 2015-09-29 EP EP20172701.3A patent/EP3725794A1/en not_active Withdrawn
- 2015-09-29 AU AU2015329767A patent/AU2015329767B2/en active Active
-
2017
- 2017-03-09 ZA ZA2017/01723A patent/ZA201701723B/en unknown
- 2017-03-13 IL IL251125A patent/IL251125B/en active IP Right Grant
- 2017-03-30 PH PH12017500586A patent/PH12017500586A1/en unknown
- 2017-04-04 CL CL2017000819A patent/CL2017000819A1/es unknown
-
2020
- 2020-04-23 JP JP2020076624A patent/JP6967625B2/ja active Active
- 2020-05-25 CY CY20201100477T patent/CY1123061T1/el unknown
- 2020-05-26 HR HRP20200849TT patent/HRP20200849T1/hr unknown
- 2020-06-05 AU AU2020203714A patent/AU2020203714B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123061T1 (el) | Μεθοδοι διαχωρισμου διαστερεοϊσομερων φωσφορικης γεμσιταβινης | |
CL2017000712A1 (es) | Pirimidinonas como inhibidores del factor xia | |
GT201600085A (es) | Composiciones y métodos para modular los receptores x farnesoides | |
BR112018010118A2 (pt) | inibidores de cxcr2 | |
EA202092987A3 (ru) | Липид, содержащий докозапентаеновую кислоту | |
CY1124587T1 (el) | Μεθοδος για την παρασκευη toy brivaracetam | |
MX2018007782A (es) | Forma cristalina de gemcitabina. | |
EA201692312A1 (ru) | Продукты гемцитабина | |
BR112015029399A2 (pt) | produção em etapa única de uma composição de polipropileno | |
BR112017001177A2 (pt) | processo para a purificação de poliovírus a partir de culturas celulares | |
EA201692288A1 (ru) | Способ получения фосфорсодержащих циангидринов | |
EA201691006A1 (ru) | Морфологические формы гексадецилоксипропиловых сложных эфиров фосфоновой кислоты и способы их синтеза | |
MX2017001459A (es) | Sintesis de fosforamidatos. | |
CY1124164T1 (el) | Καινοτομος παρασκευη και κρυσταλλωση της ιοσιμενολης | |
MX2018002730A (es) | Proceso para producir esteres de cianhidrina que contienen fosforo. | |
MX2018002729A (es) | Proceso para la elaboracion de esteres de cianohidrina que contienen fosforo. | |
NZ720106A (en) | A process for the preparation of regadenoson | |
BR112016028801A2 (pt) | inibidores de moléculas pequenas de lfa-1 | |
EA201691362A1 (ru) | Способы получения конденсированных гетероциклических модуляторов ионных каналов | |
MX2018002726A (es) | Proceso para producir esteres de cianhidrina que contienen fosforo. | |
MX2019005785A (es) | Proceso para la purificacion de 1-(4-clorofenil)pirazol-3-ol. | |
BR112014012595A2 (pt) | processo de racemização de ácido (s)-3-carbamoilmetil-5-metil-hexanoico | |
IN2014CH00444A (el) | ||
CY1120746T1 (el) | Παιδιατρικο μασωμενο δισκιο που περιεχει αντιικο παραγοντα και μεθοδος για την παρασκευη του | |
EA201991334A1 (ru) | Пленка для селективной экстракции для применения в горнодобывающей промышленности |